Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors

被引:1
作者
Kawano, Y
Takaue, Y
Watanabe, T
Abe, T
Okamoto, Y
Iwai, A
Iwai, T
Watanabe, A
Ito, E
Makimoto, A
Nakagawa, R
Watanabe, H
Sato, J
Suenaga, K
Suzuya, H
Ohnishi, T
Kanamaru, S
Kaneko, M
Kuroda, Y
机构
[1] Univ Tokushima, Dept Pediat, Tokushima 7708503, Japan
[2] Natl Canc Ctr Hosp, Stem Cell Transplantat Unit, Tokyo 1040045, Japan
[3] Kagawa Childrens Hosp, Div Hematooncol, Kagawa 7658501, Japan
[4] Akita Univ, Dept Pediat, Akita 0108543, Japan
[5] Hirosaki Univ, Dept Pediat, Aomori 0308562, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The advantages/disadvantages of the use of peripheral blood stem cells (PBSCs) for allogeneic transplantation still need to be clarified, particularly in children. We compared the kinetics, efficacy, and safety of PBSC mobilization by granulocyte colony-stimulating factor (G-CSF) and collection by apheresis between healthy pediatric and adult donors. A total of 19 pediatric (median age, 6 years) and 25 adult healthy donors (median age, 37 years) were given 10 mu g/kg/day of G-CSF for 5 consecutive days for PBSC mobilization, which were harvested by apheresis on days 5 and/or 6. All of the donors tolerated the whole procedures. Serum trough Levels of G-CSP determined by ELISA were significantly lower in the 16 pediatric donors evaluated than in adults (n = 16) on days 3 and 4 (P < 0.05), Although the WBC counts on days 4 and 5 were significantly higher in adults than in children (P = 0.006 and 0.004, respectively), the numbers of circulating CD34+ cells/unit of blood were identical. The number of blood CD34+ cells collected per unit of blood processed was identical in both donor populations. We propose that PBSCs could be effectively mobilized and collected in small children so that they could be donors for adult patients.
引用
收藏
页码:3321 / 3324
页数:4
相关论文
共 20 条
  • [1] Anderlini P, 1997, BLOOD, V90, P903
  • [2] The Lesbian and Gay Liberation Movement in the Presbyterian Church (USA), 1974-1996
    Anderson, JD
    [J]. JOURNAL OF HOMOSEXUALITY, 1997, 34 (02) : 37 - 65
  • [3] Becker P S, 1997, Biol Blood Marrow Transplant, V3, P45
  • [4] G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective
    Faulkner, LB
    Tucci, F
    Tamburini, A
    Tintori, V
    Lippi, AA
    Bambi, F
    Malentacca, F
    Azzari, C
    Gelli, AMG
    Genovese, F
    Bernini, G
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (11) : 1091 - 1095
  • [5] FURUMOTO Y, 1997, BRIT J HAEMATOL, V97, P666
  • [6] Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998
    Goldman, JM
    Schmitz, N
    Niethammer, D
    Gratwohl, A
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (01) : 1 - 7
  • [7] OPTIMIZING DOSE AND SCHEDULING OF FILGRASTIM (GRANULOCYTE-COLONY-STIMULATING FACTOR) FOR MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN NORMAL VOLUNTEERS
    GRIGG, AP
    ROBERTS, AW
    RAUNOW, H
    HOUGHTON, S
    LAYTON, JE
    BOYD, AW
    MCGRATH, KM
    MAHER, D
    [J]. BLOOD, 1995, 86 (12) : 4437 - 4445
  • [8] New consecutive high-dose chemotherapy modality with fractionated blood stem cell support in the treatment of high-risk pediatric solid tumors: a feasibility study
    Kajiume, T
    Kawano, Y
    Takaue, Y
    Abe, T
    Watanabe, T
    Okamoto, Y
    Makimoto, A
    Suenaga, K
    Suzuya, H
    Sato, J
    Yokobayashi, A
    Hashimoto, T
    Yoshida, K
    Ishibashi, H
    Takehara, H
    Tashiro, S
    Kuroda, Y
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 (02) : 147 - 151
  • [9] Continuous monitoring of hematocrit values during apheresis for allogeneic peripheral blood stem cell collection
    Kajiume, T
    Kawano, Y
    Takaue, Y
    Abe, T
    Okamoto, Y
    Makimoto, A
    Watanabe, T
    Sato, J
    Yokobayashi, A
    Kuroda, Y
    [J]. JOURNAL OF HEMATOTHERAPY, 1998, 7 (06): : 493 - 497
  • [10] KAWANO Y, 1993, EXP HEMATOL, V21, P103